Invacare Corporation (NYSE:IVC) is expected to pay $0.01 on Oct 21, 2016. The indicated annual dividend is $0.05. Shareholders owning the stock before Oct 11, 2016 will be eligible to receive the payout. Based on Invacare Corporation’s current price of $11.71, the dividend is 0.11%. This dividend’s record date is Oct 13, 2016 and the announcement date is Aug 26, 2016. The stock increased 1.12% or $0.13 on October 7, hitting $11.71. Invacare Corporation (NYSE:IVC) has declined 14.84% since March 7, 2016 and is downtrending. It has underperformed by 22.43% the S&P500.
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The company has a market cap of $384.48 million. The Company’s geographical divisions are Europe; North America, which includes North America/Home Medical Equipment and Institutional Products Group (IPG) divisions, and Asia/Pacific. It currently has negative earnings. The Firm makes and distributes three product categories: mobility and seating, lifestyle and respiratory therapy.
Insitutional Activity: The institutional sentiment decreased to 1.3 in Q2 2016. Its down 1.58, from 2.88 in 2016Q1. The ratio worsened, as 19 funds sold all Invacare Corporation shares owned while 35 reduced positions. 19 funds bought stakes while 51 increased positions. They now own 33.23 million shares or 3.41% more from 32.13 million shares in 2016Q1.
Rhumbline Advisers accumulated 50,722 shares or 0% of the stock. Alphaone Invest Ltd Liability Co accumulated 1.53% or 341,253 shares. Los Angeles And Equity holds 0% or 23,250 shares in its portfolio. Manufacturers Life Insur The has 0% invested in the company for 22,723 shares. Moreover, Ancora Limited Liability Com has 0.15% invested in Invacare Corporation (NYSE:IVC) for 103,800 shares. Johnson Inv Counsel Inc accumulated 0.03% or 72,674 shares. Ubs Asset Mgmt Americas, a Illinois-based fund reported 18,698 shares. Jacobs Levy Equity holds 0.07% or 285,909 shares in its portfolio. Morgan Stanley has 0% invested in the company for 2,000 shares. Blackrock Fund Advsrs last reported 2.31 million shares in the company. Prudential Fin Inc, a New Jersey-based fund reported 183,346 shares. New York State Teachers Retirement System, a New York-based fund reported 75,764 shares. California Employees Retirement Systems holds 0% of its portfolio in Invacare Corporation (NYSE:IVC) for 160,328 shares. Texas Permanent School Fund holds 0% of its portfolio in Invacare Corporation (NYSE:IVC) for 23,063 shares. Franklin Res holds 0.01% or 1.21M shares in its portfolio.
Insider Transactions: Since May 2, 2016, the stock had 4 insider purchases, and 2 sales for $130,743 net activity. 375 shares were sold by LaPorte Dale C, worth $3,874. NASTAS CLIFFORD D bought $55,050 worth of Invacare Corporation (NYSE:IVC) on Friday, May 6. The insider HARRIS C MARTIN sold $5,458. $11,230 worth of Invacare Corporation (NYSE:IVC) shares were bought by LaPlaca Anthony. Another trade for 4,500 shares valued at $51,255 was bought by Monaghan Matthew E.. On Monday, May 2 the insider Shah Baiju R. bought $22,540.
More notable recent Invacare Corporation (NYSE:IVC) news were published by: Crainscleveland.com which released: “FDA identifies more problems at Invacare Corp.” on January 24, 2016, also Businesswire.com with their article: “Invacare Corporation Announces Sale of ProBasics Brand in Line with …” published on September 30, 2016, Businesswire.com published: “Marc Gibeley Joins Board of Directors of Invacare Corporation” on November 20, 2015. More interesting news about Invacare Corporation (NYSE:IVC) were released by: Businesswire.com and their article: “Invacare Corporation to Provide Update on Business Transformation at Upcoming …” published on September 12, 2016 as well as Businesswire.com‘s news article titled: “Invacare Corporation Announces Financial Results for the Second Quarter and …” with publication date: July 28, 2016.
IVC Company Profile
Invacare Corporation, incorporated on March 23, 1971, is a maker and distributor for medical equipment used in non-acute care settings. The Company’s geographical divisions are Europe, North America and Asia/Pacific. The Firm makes and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Firm sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services in the United States, Europe, Canada, New Zealand, Australia and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.